InvestorsHub Logo

BIzzy

04/23/14 1:46 AM

#88284 RE: TheBunny #88276

Building the lab is worth billions..can't make money if you have short eyes...what in the holy hell should you be doing with capital in the clear run up phase to clinical trials?...you are building a Pharma business... a load of shit exercise to be grousing about what happens to pps during this phase..ooooh the stock has dropped a nano% from its pre split price...BFD

Let's talk about the wisdom of controlling production of a unique protected medical intervention...that's hundreds of dollars per share to the nickels and dimes on the board today...

davidc2

04/23/14 8:44 AM

#88295 RE: TheBunny #88276

Other reputable companies take concrete steps to get into clinical trials and make actual (real) progress.

"Galectin Therapeutics Completes Enrollment of Second Cohort of Phase 1 Trial of GR-MD-02 for NASH (Fatty Liver Disease) With Advanced Fibrosis" 4/23/14

Here we get additional studies on top of additional studies in foreign countries. A bike riding CEO stuffing himself with PowerBars while emailing the poster on a chat board.

This just feeds into your delay scenario where they know something that it's not going to work and if that gets out it's game over on the shareholders dime.